{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Globe Life, Inc.
Is Globe Life, Inc. technically bullish or bearish?
As of October 24, 2025, Globe Life, Inc. shows a mildly bullish trend with mixed technical signals across timeframes, having outperformed the S&P 500 year-to-date and over the past year, but underperformed in the 3- and 5-year periods.
Is Globe Life, Inc. technically bullish or bearish?
As of October 24, 2025, Globe Life, Inc. shows a mildly bullish trend with mixed signals across time frames, having outperformed the S&P 500 year-to-date and over the past year, but lagging in longer-term performance.
Globe Life, Inc. Hits New 52-Week High of $147.76, Up 79.55%
Globe Life, Inc. has achieved a new 52-week high, reflecting its strong performance with a notable increase over the past year. The company, with a market capitalization of USD 13,066 million, demonstrates favorable valuation metrics and efficiency in generating profits, alongside a consistent dividend yield for shareholders.
Globe Life, Inc. Hits New 52-Week High at USD 146.18
Globe Life, Inc. has achieved a new 52-week high, reflecting its strong performance with a significant increase over the past year. The company, with a market capitalization of USD 13,066 million, showcases solid financial health, highlighted by a favorable P/E ratio and return on equity, appealing to investors.
Is Globe Life, Inc. technically bullish or bearish?
As of July 24, 2025, Globe Life, Inc. has shifted to a bullish trend with strong indicators across multiple time frames, outperforming the S&P 500 in the past month and year-to-date, though it lags in longer-term performance.
Is Globe Life, Inc. overvalued or undervalued?
As of July 23, 2025, Globe Life, Inc. is fairly valued with a P/E ratio of 10 and a PEG ratio of 0.45, positioned in the middle of its peers, and has delivered a YTD return of 28.79%, outperforming the S&P 500.
Globe Life, Inc. Hits New 52-Week High of $144.50
Globe Life, Inc. has achieved a new 52-week high, reflecting a strong performance with a notable increase over the past year. The company, with a market capitalization of USD 13,066 million, showcases effective management through a solid return on equity and competitive valuation metrics.
Is Globe Life, Inc. overvalued or undervalued?
As of May 8, 2025, Globe Life, Inc. is considered undervalued with an attractive valuation grade, supported by a low P/E ratio of 10.14, a PEG ratio of 0.45, a strong ROE of 20.53%, and a stock return of 47.01% over the past year, outperforming the S&P 500.
Is Globe Life, Inc. technically bullish or bearish?
As of April 4, 2025, the trend is mildly bullish due to daily moving averages and monthly MACD signals, but caution is advised as weekly indicators show mixed signals.
Who are in the management team of Globe Life, Inc.?
As of March 2022, the management team of Globe Life, Inc. is led by Co-Chairmen and Co-CEOs Gary Coleman and Larry Hutchison, along with several independent directors, including Robert Ingram, Charles Adair, Linda Addison, Marilyn Alexander, and Cheryl Alston.
What does Globe Life, Inc. do?
Globe Life, Inc. is an insurance holding company offering life and health insurance products and annuities, with a market cap of approximately $11.3 billion and a quarterly net profit of $255 million as of March 2025. Key metrics include a P/E ratio of 10.00 and a dividend yield of 0.84%.
How big is Globe Life, Inc.?
As of Jun 18, Globe Life, Inc. has a market capitalization of $11.30 billion, with net profit of $1.07 billion and total assets of $29.08 billion.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
